Spontaneous cover screw exposure between the first and second surgical procedure is an early complication of implant therapy, which occurs in approximately every tenth patient treated with a two-phase protocol. The greatest risk of spontaneous exposure is open communication between the oral cavity and the implant, which allows the bacterial colonization that can ultimately lead to the loss of marginal bone and jeopardize osseointegration. After diagnosing spontaneous cover screw exposure, an immediate setting of the healing abutment is recommended. In a patient whose case was presented, immediate setting of the healing abutment could not be performed due to objective reasons. On the patient’s next visit, a bone resorption in the mesial part was found radiologically. Due to the impossibility of immediate placement of the healing abutment and the occurrence of marginal bone resorption on the implant 24, during the implant opening and placement of the healing abutment, augmentation of the peri-implant mucosa with a connective tissue graft taken from the tuberosity was performed. The goal of augmentation is to increase the biological width and resistance of the peri-implant mucosa to inflammatory processes that can lead to the loss of a bone that was already compromised, and to improve peri-implant pink aesthetics. The connective tissue graft, which is taken from the palate or tuberosity, is the gold standard for soft tissue augmentation. Due to the donor comorbidity that occurs when taking a graft, alternative techniques, whose main advantage is the absence of a donor site and easier postoperative course, have been developed, while the results of increasing thickness are approximate but still statistically weaker compared to a connective tissue graft. Augmentation with a connective tissue graft is not a routine procedure for spontaneous cover screw exposure, especially when it is possible to immediately place a healing abutment. In situations such as the one presented, when a certain bone resorption occurs, augmentation of the peri-implant mucosa with a connective tissue graft or an alternative technique is the therapy of choice.